Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

14.21
Delayed Data
As of Jul 30
 -0.60 / -4.05%
Today’s Change
1.86
Today|||52-Week Range
19.68
+169.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization183.0K190.0K184.0K178.0K
 
 
 
 
 
 
Operating ExpensesGross Income-183.0K-190.0K-184.0K-178.0K
 
 
 
 
 
General Expenses4.2M4.0M3.7M5.3M
 
 
 
 
 
Research And Development2.8M2.4M1.6M2.3M
 
 
 
 
 
Total Operating Expenses4.4M4.2M3.8M5.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-4.2M-3.8M-5.5M
 
 
 
 
 
Extraordinary Credit1.1M3.0M--0.00
 
 
 
Extraordinary Charge-308.0K0.00-4.5M-10.3M
 
 
 
 
Interest Expense On Debt35.0K35.0K34.0K34.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-1.2M-8.4M-15.8M
 
 
 
 
 
Net Income-3.6M-1.2M-8.4M-15.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.8M25.4M23.5M24.9M
 
 
 
 
 
Shares To Calculate EPS Diluted21.8M25.4M23.5M24.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.04-$0.36-$2.56
 
 
 
 
 
EPS Diluted-$0.16-$0.04-$0.36-$0.64